Katie Thoren

2.2k total citations
42 papers, 1.1k citations indexed

About

Katie Thoren is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Katie Thoren has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Hematology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Katie Thoren's work include Multiple Myeloma Research and Treatments (16 papers), Malaria Research and Control (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Katie Thoren is often cited by papers focused on Multiple Myeloma Research and Treatments (16 papers), Malaria Research and Control (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Katie Thoren collaborates with scholars based in United States, France and Australia. Katie Thoren's co-authors include Bryan A. Krantz, Geoffrey K. Feld, Alexander F. Kintzer, Evan R. Williams, Harry J. Sterling, Kara L. Lynch, Jennifer M. Colby, James M. Berger, Ken C. Dong and Michael Daly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Katie Thoren

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katie Thoren United States 20 746 278 224 179 124 42 1.1k
Keding Cheng Canada 17 844 1.1× 54 0.2× 41 0.2× 75 0.4× 62 0.5× 37 1.5k
Erica M. Pasini Netherlands 19 426 0.6× 52 0.2× 114 0.5× 137 0.8× 21 0.2× 33 1.5k
James D. Chang United States 19 729 1.0× 235 0.8× 20 0.1× 70 0.4× 86 0.7× 55 1.7k
Daniel Deredge United States 17 442 0.6× 55 0.2× 29 0.1× 133 0.7× 39 0.3× 49 843
Rupesh Kumar United States 15 838 1.1× 77 0.3× 20 0.1× 30 0.2× 104 0.8× 21 1.0k
Bjoern Meyer Germany 22 1.0k 1.4× 63 0.2× 38 0.2× 403 2.3× 46 0.4× 41 1.6k
Corey Levenson United States 16 611 0.8× 96 0.3× 66 0.3× 34 0.2× 49 0.4× 25 984
Makoto Kawai Japan 19 487 0.7× 74 0.3× 51 0.2× 18 0.1× 23 0.2× 59 1.5k
Charles David New Zealand 7 600 0.8× 93 0.3× 12 0.1× 39 0.2× 39 0.3× 14 995
Arie Schouten Netherlands 13 388 0.5× 54 0.2× 61 0.3× 43 0.2× 38 0.3× 27 938

Countries citing papers authored by Katie Thoren

Since Specialization
Citations

This map shows the geographic impact of Katie Thoren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Thoren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Thoren more than expected).

Fields of papers citing papers by Katie Thoren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Thoren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Thoren. The network helps show where Katie Thoren may publish in the future.

Co-authorship network of co-authors of Katie Thoren

This figure shows the co-authorship network connecting the top 25 collaborators of Katie Thoren. A scholar is included among the top collaborators of Katie Thoren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie Thoren. Katie Thoren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thoren, Katie, et al.. (2024). Isatuximab-Specific Immunofixation Electrophoresis Assay to Remove Interference in Serum M-Protein Measurement in Patients with Multiple Myeloma. The Journal of Applied Laboratory Medicine. 9(4). 661–671. 3 indexed citations
2.
Thoren, Katie, Dan Qu, James E. Hoffman, et al.. (2024). Enhanced Detection of M-Protein in Non-Secretory and Oligo-Secretory Multiple Myeloma Using MALDI-TOF Mass Spectrometry. Blood. 144(Supplement 1). 6847–6847.
3.
Thoren, Katie, et al.. (2024). Excess Risk of Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Screened Cohort of Patients with Gaucher Disease (GD). Blood. 144(Supplement 1). 3294–3294. 1 indexed citations
5.
Zeig‐Owens, Rachel, David G. Goldfarb, Benjamin J. Luft, et al.. (2022). Myeloma precursor disease (MGUS) among rescue and recovery workers exposed to the World Trade Center disaster. Blood Cancer Journal. 12(8). 120–120. 2 indexed citations
6.
Maclachlan, Kylee, Neil Came, Benjamin Diamond, et al.. (2021). Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic use. Pathology. 53(3). 385–399. 16 indexed citations
7.
Eveillard, Marion, Neha Korde, Benjamin Diamond, et al.. (2021). Using MALDI-TOF mass spectrometry in peripheral blood for the follow up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy. Clinica Chimica Acta. 516. 136–141. 8 indexed citations
8.
Thoren, Katie, Scott T. Avecilla, Virginia M. Klimek, & Cheryl Goss. (2020). A novel method for the laboratory workup of anaphylactic transfusion reactions in haptoglobin‐deficient patients. Transfusion. 60(4). 682–687. 2 indexed citations
9.
Diamond, Benjamin, Even H Rustad, Kylee Maclachlan, et al.. (2020). Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarity. Blood Reviews. 46. 100732–100732. 17 indexed citations
10.
Thoren, Katie, et al.. (2019). Identification of gamma heavy chain disease using MALDI-TOF mass spectrometry. Clinical Biochemistry. 77. 57–61. 4 indexed citations
11.
Thoren, Katie, et al.. (2019). MALDI-TOF mass spectrometry distinguishes daratumumab from M-proteins. Clinica Chimica Acta. 492. 91–94. 33 indexed citations
12.
Scordo, Michael, Valkal Bhatt, Patrick Hilden, et al.. (2019). Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(8). 1526–1535. 17 indexed citations
13.
Thoren, Katie. (2018). Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease. Seminars in Hematology. 55(1). 41–43. 37 indexed citations
14.
Colby, Jennifer M., Katie Thoren, & Kara L. Lynch. (2016). Optimization and Validation of High-Resolution Mass Spectrometry Data Analysis Parameters. Journal of Analytical Toxicology. 41(1). 1–5. 29 indexed citations
15.
Thoren, Katie, Jennifer M. Colby, Sarah Shugarts, Alan H.B. Wu, & Kara L. Lynch. (2015). Comparison of Information-Dependent Acquisition on a Tandem Quadrupole TOF vs a Triple Quadrupole Linear Ion Trap Mass Spectrometer for Broad-Spectrum Drug Screening. Clinical Chemistry. 62(1). 170–178. 67 indexed citations
16.
Brown, Michael J., Katie Thoren, & Bryan A. Krantz. (2015). Role of the α Clamp in the Protein Translocation Mechanism of Anthrax Toxin. Journal of Molecular Biology. 427(20). 3340–3349. 12 indexed citations
17.
Orengo, James P., et al.. (2013). Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion. Clinical Toxicology. 51(10). 1230–1234. 23 indexed citations
18.
Thoren, Katie, et al.. (2013). Metformin overdose-induced hypoglycemia in the absence of other antidiabetic drugs. Clinical Toxicology. 51(5). 444–447. 38 indexed citations
19.
Brown, Michael J., Katie Thoren, & Bryan A. Krantz. (2011). Charge Requirements for Proton Gradient-driven Translocation of Anthrax Toxin. Journal of Biological Chemistry. 286(26). 23189–23199. 30 indexed citations
20.
Feld, Geoffrey K., et al.. (2011). Domain Flexibility Modulates the Heterogeneous Assembly Mechanism of Anthrax Toxin Protective Antigen. Journal of Molecular Biology. 415(1). 159–174. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026